Cited 0 times in
Are Bleeding Events Valid as a Surrogate Endpoint for Mortality in Cardiovascular Clinical Trials?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 유승찬 | - |
dc.date.accessioned | 2024-07-01T07:02:11Z | - |
dc.date.available | 2024-07-01T07:02:11Z | - |
dc.date.issued | 2023-05 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/199923 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier Inc. | - |
dc.relation.isPartOf | JACC. Advances | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Are Bleeding Events Valid as a Surrogate Endpoint for Mortality in Cardiovascular Clinical Trials? | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Biomedical Systems Informatics (의생명시스템정보학교실) | - |
dc.contributor.googleauthor | Seng Chan You | - |
dc.identifier.doi | 10.1016/j.jacadv.2023.100335 | - |
dc.contributor.localId | A02478 | - |
dc.relation.journalcode | J04618 | - |
dc.identifier.eissn | 2772-963X | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S2772963X23001096 | - |
dc.contributor.alternativeName | You, Seng Chan | - |
dc.contributor.affiliatedAuthor | 유승찬 | - |
dc.citation.volume | 2 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 100335 | - |
dc.identifier.bibliographicCitation | JACC. Advances, Vol.2(3) : 100335, 2023-05 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.